AstraZeneca PLC AZN-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 10:00 AM BST
8,235.00quote price arrow down-33.00 (-0.40%)
52 week range
6,499.80 - 8,923.00

...

Loading . . .
  • Open8,271.00
  • Day High8,300.00
  • Day Low8,193.00
  • Prev Close8,268.00
  • 52 Week High8,923.00
  • 52 Week High Date07/30/20
  • 52 Week Low6,499.80
  • 52 Week Low Date05/21/21

Key Stats

  • Market Cap151,382.56M
  • Shares Out1,312.79M
  • 10 Day Average Volume5.17M
  • Dividend202.20
  • Dividend Yield2.46%
  • Beta0.16
  • YTD % Change12.33

KEY STATS

  • Open8,271.00
  • Day High8,300.00
  • Day Low8,193.00
  • Prev Close8,268.00
  • 52 Week High8,923.00
  • 52 Week High Date07/30/20
  • 52 Week Low6,499.80
  • 52 Week Low Date05/21/21
  • Market Cap151,382.56M
  • Shares Out1,312.79M
  • 10 Day Average Volume5.17M
  • Dividend202.20
  • Dividend Yield2.46%
  • Beta0.16
  • YTD % Change12.33

RATIOS/PROFITABILITY

  • EPS (TTM)207.66
  • P/E (TTM)39.66
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/12/2021
  • Div Amount64.80
  • Split Date-
  • Split Factor-

Related Video

VIDEO1:3501:35
Jon's latest options trades

Profile

MORE
AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of...
Leif Johansson
Non-Executive Chairman
Pascal Soriot
Chief Executive Officer
Marc Dunoyer
Chief Financial Officer
Ruud Dobber Ph.D.
Executive Vice President
Menelas Pangalos
Executive Vice President
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom